Diagnosis and Treatment of Primary Aldosteronism: How Aggressive Should We Be?
Webcast Webcast

Diagnosis and Treatment of Primary Aldosteronism: How Aggressive Should We Be?


Co-sponsored by the Duke University Health System Department of Clinical Education and Professional Development and Med-IQ.

Duke MedicineMed-IQ

Released:
6/20/2016
Expires:
6/19/2017
PDF:

Maximum Credits:

0.75

Webcast Webcast
Released:
6/20/2016

Expires:
6/19/2017

PDF:

Maximum Credits:
0.75
Webcast Webcast

Released:
6/20/2016
Expires:
6/19/2017
PDF:


Maximum Credits:
0.75


Overview: In this Webcast, faculty discuss primary aldosteronism as a common cause of secondary hypertension, explain the diagnostic algorithm for patients suspected of having primary aldosteronism, and explore the surgical and medical treatment options available for patients with a positive diagnosis.

CME Information:

Faculty
Elizabeth Campbell, MD
Endocrinology Fellow, Department of Medicine
Duke University School of Medicine
Durham, NC

David D’Alessio, MD
Professor, Department of Medicine
Associate Director, Duke Molecular Physiology Institute
Chief, Division of Endocrinology, Metabolism, and Nutrition
Duke University School of Medicine
Durham, NC

Activity Planners
Stephanie Larson, PhD
Clinical Content Manager
Med-IQ
Baltimore, MD

Amy Sison
Director of Continuing Medical Education
Med-IQ
Baltimore, MD

Learning Objectives
Upon completion, participants should be able to:

  • Describe the causes of secondary hypertension and the prevalence of primary aldosteronism
  • Discuss the diagnostic approach to primary aldosteronism
  • Compare medical and surgical approaches in patients with primary aldosteronism

Target Audience
This activity is intended for endocrinologists, nephrologists, and primary care physicians.

Series Overview/Statement of Need
Primary aldosteronism is a common cause of secondary hypertension. It was previously believed to account for approximately 1% of hypertensive cases, but recent data suggest that more than 10% of patients with hypertension, both in primary care and specialty clinics, have primary aldosteronism that contributes to their hypertensive state. To avoid the morbidity associated with chronic hypertension, it is important that clinicians be able to identify patients who should be screened for this condition and understand how to address abnormal results with either surgical or pharmacologic management options.

Sponsorship Statements
Co-sponsored by the Duke University Health System Department of Clinical Education and Professional Development and Med-IQ.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses, nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CME material, watch the Webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Original Release Date: June 20, 2016
Expiration Date: June 19, 2017
Estimated Time to Complete This Activity: 45 minutes

The evaluation, attestation, and post-test may be accessed by clicking the “Get Credit” tab at the bottom of the Webcast activity.

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.

Elizabeth Campbell, MD, has indicated no real or apparent conflicts.

David D’Alessio, MD
Consulting fees/advisory boards: Intarcia Therapeutics, Inc., Lilly USA, LLC, Merck & Co., Inc., Novo Nordisk

The peer reviewers and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or e-mail info@med-iq.com.

Hardware/Software Requirements
Operating System
Microsoft Windows® 2000, XP, Vista
Mac OS 10.1 or later

Browser
Microsoft Internet Explorer 6.0 or later

Mozilla Firefox 5.0 or later
Download: http://www.mozilla.org/en-US/firefox/new/

Google Chrome
Download: http://www.google.com/chrome

Apple Safari
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/

Connection Type
High bandwidth (300k) is strongly recommended
Low bandwidth (100k) results in less than optimal quality
Dial-up/modem is not recommended

For technical support, go to https://www.med-iq.com/index.cfm?fuseaction=content.support.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.Med-IQ.com/privacy-statement/ .

Sponsorship Statement
Co-sponsored by the Duke University School of Medicine and Med-IQ.

Copyright
© 2016 Duke University Health System and Med-IQ®. All rights reserved.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

Our website uses cookies to improve your experience. To learn more about the cookies we use, please visit our Privacy Notice and Terms of Use.